This inventor holds 1 USPTO granted patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Ilan Babai: Innovator in Vaccine Development
Introduction
Ilan Babai is a notable inventor based in Petach Tivka, Israel. He has made significant contributions to the field of immunology, particularly in the development of innovative vaccine technologies. His work focuses on enhancing the efficacy of influenza vaccines through advanced methodologies.
Latest Patents
Ilan Babai holds a patent for a liposomal influenza vaccine composition and method. This patent describes subunit influenza vaccines that contain an influenza H/N antigen and a cytokine immunopotentiator. Notably, at least one, and preferably both, of these components are encapsulated in liposomes. The vaccines are designed to stimulate a strong humoral and cytotoxic T lymphocyte (CTL) response. Additionally, the patent outlines methods of immunization using these advanced vaccines.
Career Highlights
Ilan Babai is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore and develop groundbreaking vaccine technologies. His innovative approach has the potential to significantly impact public health by improving vaccine effectiveness.
Collaborations
Ilan has collaborated with notable colleagues in his field, including Eliezer Kedar and Yechezkel Barenholz. These collaborations have fostered a productive environment for research and development, leading to advancements in vaccine technology.
Conclusion
Ilan Babai's contributions to vaccine development, particularly through his patented liposomal influenza vaccine, highlight his role as an innovator in the field. His work continues to pave the way for more effective immunization strategies.